Superoxide dismutase administration: A review of proposed human uses

AC Rosa, D Corsi, N Cavi, N Bruni, F Dosio - Molecules, 2021 - mdpi.com
Superoxide dismutases (SODs) are metalloenzymes that play a major role in antioxidant
defense against oxidative stress in the body. SOD supplementation may therefore trigger the …

The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis

A Kowalczyk, P Kleniewska, M Kolodziejczyk… - Archivum immunologiae …, 2015 - Springer
Abstract Endothelin-1 (ET-1) is a potent endogenous vasoconstrictor, mainly secreted by
endothelial cells. It acts through two types of receptors: ETA and ETB. Apart from a …

Comprehensive review of cardiovascular toxicity of drugs and related agents

P Mladěnka, L Applová, J Patočka… - Medicinal research …, 2018 - Wiley Online Library
Cardiovascular diseases are a leading cause of morbidity and mortality in most developed
countries of the world. Pharmaceuticals, illicit drugs, and toxins can significantly contribute to …

Mitochondrial dysfunction in lung ageing and disease

SM Cloonan, K Kim, P Esteves, T Trian… - European Respiratory …, 2020 - Eur Respiratory Soc
Mitochondrial biology has seen a surge in popularity in the past 5 years, with the emergence
of numerous new avenues of exciting mitochondria-related research including …

Role for DNA damage signaling in pulmonary arterial hypertension

J Meloche, A Pflieger, M Vaillancourt, R Paulin… - Circulation, 2014 - Am Heart Assoc
Background—Pulmonary arterial hypertension (PAH) is associated with sustained
inflammation known to promote DNA damage. Despite these unfavorable environmental …

Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach

R Nogueira-Ferreira, R Vitorino, R Ferreira… - Pulmonary …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is responsible for the premature death mainly
because of progressive and severe heart failure. This disease is characterized by increased …

Endothelin receptor antagonists: status quo and future perspectives for targeted therapy

FC Enevoldsen, J Sahana, M Wehland… - Journal of clinical …, 2020 - mdpi.com
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …

The role of endothelin-1 in pulmonary arterial hypertension

AH Chester, MH Yacoub - Global Cardiology Science and Practice, 2014 - qscience.com
Pulmonary arterial hypertension (PAH) is a rare but debilitating disease, which if left
untreated rapidly progresses to right ventricular failure and eventually death. In the quest to …

[HTML][HTML] Current and emerging therapeutic approaches to pulmonary hypertension

M Bisserier, N Pradhan, L Hadri - Reviews in cardiovascular …, 2020 - ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of
multifactorial etiology. Most of the available drugs and FDA-approved therapies for treating …

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

A Weiss, MC Neubauer, D Yerabolu… - Nature …, 2019 - nature.com
Pulmonary arterial hypertension (PAH) is a devastating disease with poor prognosis and
limited therapeutic options. We screened for pathways that may be responsible for the …